Search Results 1731-1740 of 203314 for Treatment
About this study. The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...
The main purpose of this study is to assess the effectiveness and safety of treatment with anetumab ravtansine versus vinorelbine for progression free survival ...
About this study. The overall goal is to investigate the value of ultrasound imaging of tumor vasculature as a new biomarker for early treatment evaluation.
The immunosuppressive comparators will be Everolimus and Tacrolimus therapy compared to Tacrolimus and Mycophenolic acid/Mycophenolate Mofetil. Primary outcomes ...
This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute ...
Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the ...
Treatment options for advanced colorectal cancer have improved. Learn how Mayo Clinic is helping patients with late stage colorectal cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!